151 related articles for article (PubMed ID: 3476167)
1. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.
Melo JV; Catovsky D; Galton DA
Blood Cells; 1987; 12(2):339-53. PubMed ID: 3476167
[TBL] [Abstract][Full Text] [Related]
2. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.
Melo JV; Catovsky D; Galton DA
Br J Haematol; 1986 Jun; 63(2):377-87. PubMed ID: 3487341
[TBL] [Abstract][Full Text] [Related]
3. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features.
Melo JV; Catovsky D; Gregory WM; Galton DA
Br J Haematol; 1987 Jan; 65(1):23-9. PubMed ID: 3468997
[TBL] [Abstract][Full Text] [Related]
4. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.
Melo JV; Catovsky D; Galton DA
Br J Haematol; 1986 Sep; 64(1):77-86. PubMed ID: 3463362
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
[TBL] [Abstract][Full Text] [Related]
7. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
8. [B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].
Muraoka A; Asami M; Ueno H; Yoneda R; Ogura M; Oribe T; Suzuki K; Maeda M; Chinzei T; Yamashiro K
Rinsho Ketsueki; 1990 Nov; 31(11):1840-4. PubMed ID: 2287070
[TBL] [Abstract][Full Text] [Related]
9. [Chronic lymphocytic leukemia in Japan].
Kobayashi T; Kita K; Ohno T; Shirakawa S
Rinsho Ketsueki; 1990 May; 31(5):554-63. PubMed ID: 2203917
[TBL] [Abstract][Full Text] [Related]
10. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
11. B-lineage prolymphocytic leukemia as a distinct clinicopathologic entity.
Katayama I; Aiba M; Pechet L; Sullivan JL; Roberts P; Humphreys RE
Am J Pathol; 1980 May; 99(2):399-412. PubMed ID: 6929655
[TBL] [Abstract][Full Text] [Related]
12. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).
Bacher U; Kern W; Schoch C; Hiddemann W; Haferlach T
Ann Hematol; 2004 Jun; 83(6):349-55. PubMed ID: 15034762
[TBL] [Abstract][Full Text] [Related]
15. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements.
Melo JV; Wardle J; Chetty M; England J; Lewis SM; Galton DA; Catovsky D
Br J Haematol; 1986 Nov; 64(3):469-78. PubMed ID: 3466642
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.
Viñolas N; Reverter JC; Urbano-Ispizua A; Montserrat E; Rozman C
Blood Cells; 1987; 12(2):457-70. PubMed ID: 3620708
[TBL] [Abstract][Full Text] [Related]
17. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
18. Prolymphocytic leukemia.
Stone RM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
[TBL] [Abstract][Full Text] [Related]
19. Prolymphocytic transformation of chronic lymphocytic leukemia. A report of three cases and review of the literature.
Ghani AM; Krause JR; Brody JP
Cancer; 1986 Jan; 57(1):75-80. PubMed ID: 3455676
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
Hicks MJ; Grogan TM; Fielder K; Spier CM
Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
